BioCentury | Nov 14, 2020
Deals

Innovation in a hurry: China biotechs see a fast track to global stage – survey

...access.Li Chen, founder, president and CEO of Hua Medicine Ltd....
...Simone Fishburn Hutchison China MediTech Ltd. Sofinnova Partners Qiming Venture Partners Hua Medicine Ltd. CStone...
BioCentury | Nov 6, 2020
Management Tracks

BeiGene’s pathfinding CFO Liang to retire

...head of biotechnology equity research, for BeiGene in 2015. Multiple companies have since followed suit, including Hua Medicine Ltd....
BioCentury | Sep 19, 2020
Politics, Policy & Law

Biopharma companies, investors scrambling to work around WeChat ban

...of Arch Venture Partners and chairman of Hua Medicine Ltd....
BioCentury | Aug 17, 2020
Deals

China’s Hua looks to Bayer to commercialize lead diabetes therapy on its own turf

...deal fills a hole in its China portfolio.Hua Medicine Ltd....
...were always our preferred partner.” George Lin, Hua Medicine...
...with Glucobay,” Lin said. “The beauty for Hua Medicine...
BioCentury | Jul 2, 2020
Product Development

July 1 Quick Takes: Amgen gains on court win; plus Hua, J&J, argenx, Seattle Genetics-Genmab, Interprotein

...drug, failed to prove that they were invalid. Hua meets again in diabetes Phase III Hua Medicine Ltd....
...3CLpro (Coronavirus NSP5; Mpro) - Coronavirus 3C-like proteinase GCK (GK) - Glucokinase BioCentury Staff Dorzagliatin, sinogliatin (HMS5552, RO5305552) Hua Medicine Ltd. Johnson...
BioCentury | Jun 19, 2020
Product Development

Hua shows sustained benefit in diabetics with glucokinase activator

...George Lin told BioCentury hasn’t been observed with most other oral Type II diabetes drugs. Hua Medicine Ltd....
...peptide-1 (GLP-1) mGLUR5 (GRM5) - Metabotropic glutamate receptor subtype 5 Sandi Wong, Assistant Editor Dorzagliatin, sinogliatin (HMS5552, RO5305552) Hua Medicine Ltd. George...
BioCentury | May 23, 2020
Finance

Proposed legislation could deter Chinese biotechs from listing in U.S.

...said. Four biotechs were among the five life sciences companies who lost more than 8%: Hua Medicine Ltd....
BioCentury | May 16, 2020
Finance

HKEX’s biotech chapter shows all the signs of a sustainable market

...liquidity for most stocks. For instance, the second biotech IPO out of the gate was Hua Medicine Ltd....
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...of global health sciences and regulatory affairs at The Medicines Co. (NASDAQ:MDCO). Shanghai-based diabetes company Hua Medicine Ltd....
...Symphony Health Solutions. BioCentury Staff Millendo Therapeutics Inc. Enterprise Therapeutics Ltd. GenMark Diagnostics Inc. Vividion Therapeutics Inc. Palleon Pharmaceuticals Inc. Akcea Therapeutics Inc. Hua Medicine Ltd. Immunomedics...
BioCentury | Feb 11, 2020
Product Development

vTv’s potential first-in-class therapy heading for Phase III after clearing Type I diabetes hurdle

...Type I diabetes. Still, he pointed to the development in China of another GCK activator, Hua Medicine Ltd....
Items per page:
1 - 10 of 105
BioCentury | Nov 14, 2020
Deals

Innovation in a hurry: China biotechs see a fast track to global stage – survey

...access.Li Chen, founder, president and CEO of Hua Medicine Ltd....
...Simone Fishburn Hutchison China MediTech Ltd. Sofinnova Partners Qiming Venture Partners Hua Medicine Ltd. CStone...
BioCentury | Nov 6, 2020
Management Tracks

BeiGene’s pathfinding CFO Liang to retire

...head of biotechnology equity research, for BeiGene in 2015. Multiple companies have since followed suit, including Hua Medicine Ltd....
BioCentury | Sep 19, 2020
Politics, Policy & Law

Biopharma companies, investors scrambling to work around WeChat ban

...of Arch Venture Partners and chairman of Hua Medicine Ltd....
BioCentury | Aug 17, 2020
Deals

China’s Hua looks to Bayer to commercialize lead diabetes therapy on its own turf

...deal fills a hole in its China portfolio.Hua Medicine Ltd....
...were always our preferred partner.” George Lin, Hua Medicine...
...with Glucobay,” Lin said. “The beauty for Hua Medicine...
BioCentury | Jul 2, 2020
Product Development

July 1 Quick Takes: Amgen gains on court win; plus Hua, J&J, argenx, Seattle Genetics-Genmab, Interprotein

...drug, failed to prove that they were invalid. Hua meets again in diabetes Phase III Hua Medicine Ltd....
...3CLpro (Coronavirus NSP5; Mpro) - Coronavirus 3C-like proteinase GCK (GK) - Glucokinase BioCentury Staff Dorzagliatin, sinogliatin (HMS5552, RO5305552) Hua Medicine Ltd. Johnson...
BioCentury | Jun 19, 2020
Product Development

Hua shows sustained benefit in diabetics with glucokinase activator

...George Lin told BioCentury hasn’t been observed with most other oral Type II diabetes drugs. Hua Medicine Ltd....
...peptide-1 (GLP-1) mGLUR5 (GRM5) - Metabotropic glutamate receptor subtype 5 Sandi Wong, Assistant Editor Dorzagliatin, sinogliatin (HMS5552, RO5305552) Hua Medicine Ltd. George...
BioCentury | May 23, 2020
Finance

Proposed legislation could deter Chinese biotechs from listing in U.S.

...said. Four biotechs were among the five life sciences companies who lost more than 8%: Hua Medicine Ltd....
BioCentury | May 16, 2020
Finance

HKEX’s biotech chapter shows all the signs of a sustainable market

...liquidity for most stocks. For instance, the second biotech IPO out of the gate was Hua Medicine Ltd....
BioCentury | Feb 15, 2020
Management Tracks

Immunomedics names Itri CMO; plus Hua, GenMark, AAM, Vividion, Sophia Genetics, Enterprise, Encoded, Palleon and more

...of global health sciences and regulatory affairs at The Medicines Co. (NASDAQ:MDCO). Shanghai-based diabetes company Hua Medicine Ltd....
...Symphony Health Solutions. BioCentury Staff Millendo Therapeutics Inc. Enterprise Therapeutics Ltd. GenMark Diagnostics Inc. Vividion Therapeutics Inc. Palleon Pharmaceuticals Inc. Akcea Therapeutics Inc. Hua Medicine Ltd. Immunomedics...
BioCentury | Feb 11, 2020
Product Development

vTv’s potential first-in-class therapy heading for Phase III after clearing Type I diabetes hurdle

...Type I diabetes. Still, he pointed to the development in China of another GCK activator, Hua Medicine Ltd....
Items per page:
1 - 10 of 105